Swedencare AB (publ) Q2 2026 Earnings Call Transcript
Swedencare AB (publ) held its Q2 2026 earnings call, led by CEO Hakan Lagerberg and CFO Jenny Graflind, with NaturVet's CEO Geoff Granger joining. The company reported a solid quarter with resilient growth and strong cash generation despite volatile markets. Organic growth reached 7%, below the company's goal but still outperforming the market. Operational EBITDA was SEK 129.4 million with a 19.3% margin, and operating cash flow improved to SEK 78 million. Performance was mixed across segments: Europe and Production delivered strong organic growth of 19% and 25% respectively, while North America declined 3% organically due to delayed big box launch deliveries and temporary effects in the U.S. veterinary channel. Management expects North America to strengthen in the second half of the year as delayed launches and online initiatives scale up.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page itself is projected from evidence records.
- Current automated evidence projection